Clostridium butyricum (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Clostridium butyricum" in English language version.

refsWebsite

Global rank English rank

17nih.gov

4^th place

13doi.org

2^nd place

3semanticscholar.org

11^th place

8^th place

2food.gov.uk

6,369^th place

4,833^rd place

1microbiologyresearch.org

low place

1worldcat.org

5^th place

1jst.go.jp

1,903^rd place

2,346^th place

1web.archive.org

1^st place

doi.org

Seki H, Shiohara M, Matsumura T, Miyagawa N, Tanaka M, Komiyama A, et al. (February 2003). "Prevention of antibiotic-associated diarrhea in children by Clostridium butyricum MIYAIRI". Pediatrics International. 45 (1): 86–90. doi:10.1046/j.1442-200x.2003.01671.x. PMID 12654076. S2CID 23451154.
Meng X, Karasawa T, Zou K, Kuang X, Wang X, Lu C, et al. (August 1997). "Characterization of a neurotoxigenic Clostridium butyricum strain isolated from the food implicated in an outbreak of food-borne type E botulism". Journal of Clinical Microbiology. 35 (8): 2160–2162. doi:10.1128/JCM.35.8.2160-2162.1997. PMC 229926. PMID 9230405.
Skerman VB, McGowan V, Sneath PH (1980). "Approved Lists of Bacterial Names". International Journal of Systematic and Evolutionary Microbiology. 30 (1): 225–420. doi:10.1099/00207713-30-1-225. ISSN 1466-5034.
Ariyoshi T, Hagihara M, Takahashi M, Mikamo H (February 2022). "Effect of Clostridium butyricum on Gastrointestinal Infections". Biomedicines. 10 (2): 483. doi:10.3390/biomedicines10020483. PMC 8962260. PMID 35203691.
Ito I, Hayashi T, Iguchi A, Endo H, Nakao M, Kato S, et al. (April 1997). "[Effects of administration of Clostridium butyricum to patients receiving long-term tube feeding]" [Effect of butyric acid bacteria suspension on intestinal mucosal function in elderly patients undergoing tube feeding]. Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics (in Japanese). 34 (4): 298–304. doi:10.3143/geriatrics.34.298. PMID 9212685.
Seki H, Shiohara M, Matsumura T, Miyagawa N, Tanaka M, Komiyama A, et al. (February 2003). "Prevention of antibiotic-associated diarrhea in children by Clostridium butyricum MIYAIRI". Pediatrics International. 45 (1): 86–90. doi:10.1046/j.1442-200X.2003.01671.x. PMID 12654076. S2CID 23451154.
Maebashi M, Sato T, Makino Y, Furukawa Y, Inomata T (1998). "Implication of 'Harmful' Intestinal Microflora in the Pathogenesis of Diseases with Immune Dysfunction". Bioscience and Microflora. 17 (1): 55–60. doi:10.12938/bifidus1996.17.55. S2CID 54698273.
Woo TD, Oka K, Takahashi M, Hojo F, Osaki T, Hanawa T, et al. (November 2011). "Inhibition of the cytotoxic effect of Clostridium difficile in vitro by Clostridium butyricum MIYAIRI 588 strain". Journal of Medical Microbiology. 60 (Pt 11): 1617–1625. doi:10.1099/jmm.0.033423-0. PMID 21700738.
Shimbo I, Yamaguchi T, Odaka T, Nakajima K, Koide A, Koyama H, et al. (December 2005). "Effect of Clostridium butyricum on fecal flora in Helicobacter pylori eradication therapy". World Journal of Gastroenterology. 11 (47): 7520–7524. doi:10.3748/wjg.v11.i47.7520. PMC 4725182. PMID 16437727.
Li Y, Liu M, Liu H, Sui X, Liu Y, Wei X, et al. (25 March 2021). "The Anti-Inflammatory Effect and Mucosal Barrier Protection of Clostridium butyricum RH2 in Ceftriaxone-Induced Intestinal Dysbacteriosis". Frontiers in Cellular and Infection Microbiology. 11: 647048. doi:10.3389/fcimb.2021.647048. PMC 8027357. PMID 33842393.
Chathuranga K, Shin Y, Uddin MB, Paek J, Chathuranga WA, Seong Y, et al. (10 October 2023). "The novel immunobiotic Clostridium butyricum S-45-5 displays broad-spectrum antiviral activity in vitro and in vivo by inducing immune modulation". Frontiers in Immunology. 14: 1242183. doi:10.3389/fimmu.2023.1242183. PMC 10595006. PMID 37881429.
Sulthana A, Thorramamidi A, Lakshmi SG, Madempudi RS (January 2019). "Whole-Genome Shotgun Sequencing and Characterization of Probiotic Strain Clostridium butyricum UBCB 70 To Assess Its Safety". Microbiology Resource Announcements. 8 (5): e01732–18. doi:10.1128/MRA.01732-18. PMC 6357650. PMID 30714044.
Juan Z, Zhao-Ling S, Ming-Hua Z, Chun W, Hai-Xia W, Meng-Yun L, et al. (July 2017). "Oral administration of Clostridium butyricum CGMCC0313-1 reduces ovalbumin-induced allergic airway inflammation in mice". Respirology. 22 (5): 898–904. doi:10.1111/resp.12985. PMID 28122397.

food.gov.uk

acnfp.food.gov.uk

Miyarisan Pharmaceutical Co Ltd (31 January 2012). Public Version - Clostridium butyricum MIYAIRI 588 as a novel food supplement (PDF) (Report). Advisory Committee on Novel Foods and Processes. Retrieved 2 January 2024.

food.gov.uk

"Committee Paper for Discussion: Adivosry Committee for Novel Foods and Processes - Clostridium Butyricum Probtiotic" (PDF). Archived from the original (PDF) on 3 November 2013. Retrieved 8 September 2013.

jst.go.jp

jstage.jst.go.jp

Maebashi M, Sato T, Makino Y, Furukawa Y, Inomata T (1998). "Implication of 'Harmful' Intestinal Microflora in the Pathogenesis of Diseases with Immune Dysfunction". Bioscience and Microflora. 17 (1): 55–60. doi:10.12938/bifidus1996.17.55. S2CID 54698273.

microbiologyresearch.org

Skerman VB, McGowan V, Sneath PH (1980). "Approved Lists of Bacterial Names". International Journal of Systematic and Evolutionary Microbiology. 30 (1): 225–420. doi:10.1099/00207713-30-1-225. ISSN 1466-5034.

nih.gov

pubmed.ncbi.nlm.nih.gov

Seki H, Shiohara M, Matsumura T, Miyagawa N, Tanaka M, Komiyama A, et al. (February 2003). "Prevention of antibiotic-associated diarrhea in children by Clostridium butyricum MIYAIRI". Pediatrics International. 45 (1): 86–90. doi:10.1046/j.1442-200x.2003.01671.x. PMID 12654076. S2CID 23451154.
Meng X, Karasawa T, Zou K, Kuang X, Wang X, Lu C, et al. (August 1997). "Characterization of a neurotoxigenic Clostridium butyricum strain isolated from the food implicated in an outbreak of food-borne type E botulism". Journal of Clinical Microbiology. 35 (8): 2160–2162. doi:10.1128/JCM.35.8.2160-2162.1997. PMC 229926. PMID 9230405.
Ariyoshi T, Hagihara M, Takahashi M, Mikamo H (February 2022). "Effect of Clostridium butyricum on Gastrointestinal Infections". Biomedicines. 10 (2): 483. doi:10.3390/biomedicines10020483. PMC 8962260. PMID 35203691.
Ito I, Hayashi T, Iguchi A, Endo H, Nakao M, Kato S, et al. (April 1997). "[Effects of administration of Clostridium butyricum to patients receiving long-term tube feeding]" [Effect of butyric acid bacteria suspension on intestinal mucosal function in elderly patients undergoing tube feeding]. Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics (in Japanese). 34 (4): 298–304. doi:10.3143/geriatrics.34.298. PMID 9212685.
Seki H, Shiohara M, Matsumura T, Miyagawa N, Tanaka M, Komiyama A, et al. (February 2003). "Prevention of antibiotic-associated diarrhea in children by Clostridium butyricum MIYAIRI". Pediatrics International. 45 (1): 86–90. doi:10.1046/j.1442-200X.2003.01671.x. PMID 12654076. S2CID 23451154.
Woo TD, Oka K, Takahashi M, Hojo F, Osaki T, Hanawa T, et al. (November 2011). "Inhibition of the cytotoxic effect of Clostridium difficile in vitro by Clostridium butyricum MIYAIRI 588 strain". Journal of Medical Microbiology. 60 (Pt 11): 1617–1625. doi:10.1099/jmm.0.033423-0. PMID 21700738.
Shimbo I, Yamaguchi T, Odaka T, Nakajima K, Koide A, Koyama H, et al. (December 2005). "Effect of Clostridium butyricum on fecal flora in Helicobacter pylori eradication therapy". World Journal of Gastroenterology. 11 (47): 7520–7524. doi:10.3748/wjg.v11.i47.7520. PMC 4725182. PMID 16437727.
Li Y, Liu M, Liu H, Sui X, Liu Y, Wei X, et al. (25 March 2021). "The Anti-Inflammatory Effect and Mucosal Barrier Protection of Clostridium butyricum RH2 in Ceftriaxone-Induced Intestinal Dysbacteriosis". Frontiers in Cellular and Infection Microbiology. 11: 647048. doi:10.3389/fcimb.2021.647048. PMC 8027357. PMID 33842393.
Chathuranga K, Shin Y, Uddin MB, Paek J, Chathuranga WA, Seong Y, et al. (10 October 2023). "The novel immunobiotic Clostridium butyricum S-45-5 displays broad-spectrum antiviral activity in vitro and in vivo by inducing immune modulation". Frontiers in Immunology. 14: 1242183. doi:10.3389/fimmu.2023.1242183. PMC 10595006. PMID 37881429.
Sulthana A, Thorramamidi A, Lakshmi SG, Madempudi RS (January 2019). "Whole-Genome Shotgun Sequencing and Characterization of Probiotic Strain Clostridium butyricum UBCB 70 To Assess Its Safety". Microbiology Resource Announcements. 8 (5): e01732–18. doi:10.1128/MRA.01732-18. PMC 6357650. PMID 30714044.
Juan Z, Zhao-Ling S, Ming-Hua Z, Chun W, Hai-Xia W, Meng-Yun L, et al. (July 2017). "Oral administration of Clostridium butyricum CGMCC0313-1 reduces ovalbumin-induced allergic airway inflammation in mice". Respirology. 22 (5): 898–904. doi:10.1111/resp.12985. PMID 28122397.

ncbi.nlm.nih.gov

Meng X, Karasawa T, Zou K, Kuang X, Wang X, Lu C, et al. (August 1997). "Characterization of a neurotoxigenic Clostridium butyricum strain isolated from the food implicated in an outbreak of food-borne type E botulism". Journal of Clinical Microbiology. 35 (8): 2160–2162. doi:10.1128/JCM.35.8.2160-2162.1997. PMC 229926. PMID 9230405.
Ariyoshi T, Hagihara M, Takahashi M, Mikamo H (February 2022). "Effect of Clostridium butyricum on Gastrointestinal Infections". Biomedicines. 10 (2): 483. doi:10.3390/biomedicines10020483. PMC 8962260. PMID 35203691.
Shimbo I, Yamaguchi T, Odaka T, Nakajima K, Koide A, Koyama H, et al. (December 2005). "Effect of Clostridium butyricum on fecal flora in Helicobacter pylori eradication therapy". World Journal of Gastroenterology. 11 (47): 7520–7524. doi:10.3748/wjg.v11.i47.7520. PMC 4725182. PMID 16437727.
Li Y, Liu M, Liu H, Sui X, Liu Y, Wei X, et al. (25 March 2021). "The Anti-Inflammatory Effect and Mucosal Barrier Protection of Clostridium butyricum RH2 in Ceftriaxone-Induced Intestinal Dysbacteriosis". Frontiers in Cellular and Infection Microbiology. 11: 647048. doi:10.3389/fcimb.2021.647048. PMC 8027357. PMID 33842393.
Chathuranga K, Shin Y, Uddin MB, Paek J, Chathuranga WA, Seong Y, et al. (10 October 2023). "The novel immunobiotic Clostridium butyricum S-45-5 displays broad-spectrum antiviral activity in vitro and in vivo by inducing immune modulation". Frontiers in Immunology. 14: 1242183. doi:10.3389/fimmu.2023.1242183. PMC 10595006. PMID 37881429.
Sulthana A, Thorramamidi A, Lakshmi SG, Madempudi RS (January 2019). "Whole-Genome Shotgun Sequencing and Characterization of Probiotic Strain Clostridium butyricum UBCB 70 To Assess Its Safety". Microbiology Resource Announcements. 8 (5): e01732–18. doi:10.1128/MRA.01732-18. PMC 6357650. PMID 30714044.

semanticscholar.org

api.semanticscholar.org

Seki H, Shiohara M, Matsumura T, Miyagawa N, Tanaka M, Komiyama A, et al. (February 2003). "Prevention of antibiotic-associated diarrhea in children by Clostridium butyricum MIYAIRI". Pediatrics International. 45 (1): 86–90. doi:10.1046/j.1442-200x.2003.01671.x. PMID 12654076. S2CID 23451154.
Seki H, Shiohara M, Matsumura T, Miyagawa N, Tanaka M, Komiyama A, et al. (February 2003). "Prevention of antibiotic-associated diarrhea in children by Clostridium butyricum MIYAIRI". Pediatrics International. 45 (1): 86–90. doi:10.1046/j.1442-200X.2003.01671.x. PMID 12654076. S2CID 23451154.
Maebashi M, Sato T, Makino Y, Furukawa Y, Inomata T (1998). "Implication of 'Harmful' Intestinal Microflora in the Pathogenesis of Diseases with Immune Dysfunction". Bioscience and Microflora. 17 (1): 55–60. doi:10.12938/bifidus1996.17.55. S2CID 54698273.

web.archive.org

"Committee Paper for Discussion: Adivosry Committee for Novel Foods and Processes - Clostridium Butyricum Probtiotic" (PDF). Archived from the original (PDF) on 3 November 2013. Retrieved 8 September 2013.

worldcat.org

search.worldcat.org

Skerman VB, McGowan V, Sneath PH (1980). "Approved Lists of Bacterial Names". International Journal of Systematic and Evolutionary Microbiology. 30 (1): 225–420. doi:10.1099/00207713-30-1-225. ISSN 1466-5034.